The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that ...

DB-OTO, which Regeneron obtained from the 2023 acquisition of Decibel Therapeutics for $109 million, works by delivering a ...

Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...

Taking center stage at the American Society of Gene and Cell Therapy meeting was the first-ever reported case of a ...

Sponsored communities reduce timelines and increase relevance. Digital engagement allows for rapid study launches and ...

While sparking excitement among biopharma companies focused on rare and ultrarare indications, experts say FDA Commissioner ...

The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...

While the Trump administration has painted the jettisoning of staff and regulations as good for business, there are multiple ...

Since Elevidys' accelerated approval in 2023, experts have been clamoring for more data, particularly in older and ...

Currently trailing Eli Lilly and Structure Therapeutics in the oral weight loss space, Novo Nordisk strikes a deal with ...

President Donald Trump unwrapped a massive drug pricing policy as CMS prepares for the next round of Medicare drug price ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...